Navigation Links
Pharmos Corporation Reports 2010 Third Quarter Results
Date:10/27/2010

ies and benefits offset by a reduction of an accrued marketing expense that was not paid in 2009.

Nine-months Ended September 30, 2010For the nine months ended September 30, 2010, Pharmos recorded a net loss of $1.4 million, or $0.02 per share compared to a net loss of $7.3 million, or $0.17 per share for the nine months ended September 30, 2009. Total operating expenses decreased 80% to $1.3 million from $6.6 million.

Research & development expenses decreased by $3,886,173 from $4,266,337 in 2009 to $380,164 in 2010, related to the Company's completion of the Dextofisopam Phase 2b trial and the downsizing and curtailment of general research and development programs.

In the first nine months of 2010, in-process research and development costs which were related to the Vela milestone decreased by $1,180,000 from $1,180,000 in 2009 to $0 in 2010. The expense of the milestone of $1,180,000 was reflected in the 1Q 2009 results. The $1 million cash portion of the milestone expense was reversed in 4Q 2009 as the milestone criteria was ultimately not achieved.

General and administrative expenses for the first nine months of 2010 decreased by $166,123, or 15%, from $1,101,865 in 2009 to $935,742 in 2010. The primary reductions are in consultant and professional fees and various facility related expenses. This is offset by an increase in salaries and benefits, the majority of which results from higher stock compensation in 2010 and a non cash bonus reversal in 2009. Also an increase was incurred by a reduction of an accrued marketing expense that was not paid in 2009.

Other expense net, decreased by $715,036 from $791,774 in other expense in 2009 to $76,738 in other expense in 2010. The majority of this decrease is related to the conversion of debentures into equity resulting in an expense of $596,104 in 2009 and an $112,770 reduction in interest expense attributable to reduced debt outstanding in 2010.

About Pharmos Corpora
'/>"/>

SOURCE Pharmos Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
2. Pharmos Issues Business Update on Dextofisopam Trial and Financing
3. Pharmos Corporation Reports 2009 Third Quarter Results
4. Pharmos Corporation Reports Fourth Quarter and Full Year 2009 Results
5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
6. CEL-SCI Corporation Releases Letter to Shareholders
7. Alfacell Corporation to Present at UBS Global Life Sciences Conference
8. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
9. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
10. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
11. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015  The Pittsburgh Life Sciences Greenhouse (PLSG), the ... that one of its portfolio companies, Medrobotics Corporation, has ... Robotic System in the U.S.  ... Medrobotics," said John W. Manzetti , president and ... way since spinning out of The Robotics Institute at ...
(Date:8/4/2015)... , Aug. 4, 2015  Intec Pharma Ltd. (the ... company focused on developing drugs based on its proprietary ... its initial public offering in the United ... at a price to the public of $6.00 per ... the ordinary shares are being offered by the Company.  ...
(Date:8/4/2015)... 4, 2015 P&S Market ... overview, trends, DRO analysis, market segmentation, market size ... and top competitor profiles in: Global ... Development and Demand Forecast to 2020  ... Explore full reports with detailed TOC on Global ...
Breaking Medicine Technology:Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 2Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 4Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 5
... Calif., Oct. 11 Threshold,Pharmaceuticals, Inc. (Nasdaq: THLD ... analysis, it would stop enrollment in a Phase 2 ... patients with,recurrent, sensitive small cell lung cancer. The ... there would be,an adequate response rate to justify complete ...
... KineMed Inc., a,pathway-based drug discovery and development company, ... an investigational agent,to regenerate nerve cells in the ... and mood. The agent, part of a partnered ... behavioral test in a,preclinical model. The findings were ...
Cached Medicine Technology:Threshold Pharmaceuticals to Stop Enrollment in Clinical Trial 2Threshold Pharmaceuticals to Stop Enrollment in Clinical Trial 3KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 2KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 3
(Date:8/4/2015)... ... August 04, 2015 , ... Seedstock’s 4th Annual ... 3 – 4, 2015, at UC San Diego, will explore innovations that farmers ... access, and manage resources efficiently against the dueling backdrop of a lingering Western ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... Orange County, Los Angeles, Riverside, and San Bernardino, today announced that the U.S. Department ... stars indicate that 24/7 Care At Home’s agency is well on the path to ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... supplement manufacturing, label design, product packaging, and fulfillment services, joined over 200 other ... The event was held on Tuesday, July 28th at Jones Beach State Park ...
(Date:8/4/2015)... ... August 04, 2015 , ... T.E.N., an information technology and security executive networking ... Lions’ Den and Jungle Lounge 2015, which will be held from 3-6:30 p.m. Aug. ... event, eight emerging security vendors, known as “Gazelles,” will go head-to-head with the ISE® ...
(Date:8/4/2015)... Washington, D.C. (PRWEB) , ... ... ... announced that its HealthCenter personal health record (PHR) product has achieved Office ... Ambulatory and Inpatient EHR Certification from Drummond Group. HealthCenter delivers the highest ...
Breaking Medicine News(10 mins):Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:24/7 Care At Home Receives Two Stars from the VA 2Health News:24/7 Care At Home Receives Two Stars from the VA 3Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3
... Jersey women should consider the real cost of the procedure beyond ... plastic surgeon, advises of the importance of choosing a cosmetic surgeon wisely ... , ... Paramus, NJ (PRWeb) January 27, 2009 - You may be under ...
... maintain its newsworthy coverage on its Avandia information portal with the ... side effects. The type 2 diabetes drug has been linked ... ... Denver, CO (PRWEB) January 27, 2009 -- LegalView.info, the ...
... Spectrum Software, a leading software developer for medical device makers, announced ... Technical Reports, How to Manage an FDA Controlled Software Project. ... covers best practices in software team communications, software methodologies and managing ... ...
... and founder of Secrets2MyGreatBody.com reveals how people can easily and ... and best of all, keep it off without the typical diet restrictions. ... ... of best selling weight loss program Total Body Transformation System , ...
... Medicare patients treated at top-rated hospitals nationwide across ... 27 percent less likely to die, on average, ... to a study released today by HealthGrades, the ... surgery at these high-performing hospitals also have an ...
... individual physicians and the physician partnership in litigation ... announcement that Texas Attorney General Greg Abbott has ... of the state antitrust laws.The Attorney General,s Office ... injunction prohibiting Memorial Hermann from engaging in certain ...
Cached Medicine News:Health News:Interested in Breast Augmentation, New Jersey? Be Sure You Know the “Real Cost” 2Health News:Interested in Breast Augmentation, New Jersey? Be Sure You Know the “Real Cost” 3Health News:Interested in Breast Augmentation, New Jersey? Be Sure You Know the “Real Cost” 4Health News:LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects 2Health News:LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects 3Health News:New Software Technology Report for Medical Device Makers: How to Manage an FDA Controlled Software Project 2Health News:Best Selling Weight Loss Expert Finally Answers The Question: Can You Achieve Permanent Fat Loss By Eating More and Exercising Less? 2Health News:Best Selling Weight Loss Expert Finally Answers The Question: Can You Achieve Permanent Fat Loss By Eating More and Exercising Less? 3Health News:Top hospitals have 27 percent lower mortality: Annual HealthGrades study 2Health News:Top hospitals have 27 percent lower mortality: Annual HealthGrades study 3Health News:Lawyers React to Texas Attorney General's Lawsuit, Settlement Against Houston's Memorial Hermann 2
10 mm wide tip....
9 mm wide tip. 35 mm from angle to tip....
Designated most popular model or size. 4 mm wide tip....
2.5 mm x 4 mm opening. Hexagonal handle....
Medicine Products: